Title: The Role of the Laboratory in Clinical Toxicology and in the Teaching of Therapeutics
Abstract: The Journal of Clinical PharmacologyVolume 15, Issue 4 p. 230-240 The Role of the Laboratory in Clinical Toxicology and in the Teaching of Therapeutics MANUCHAIR S. EBADI Ph.D., F.C.P., MANUCHAIR S. EBADI Ph.D., F.C.P. Department of Pharmacology, University of Nebraska College of Medicine, Omaha, Nebr. 68105.Search for more papers by this author MANUCHAIR S. EBADI Ph.D., F.C.P., MANUCHAIR S. EBADI Ph.D., F.C.P. Department of Pharmacology, University of Nebraska College of Medicine, Omaha, Nebr. 68105.Search for more papers by this author First published: April 1975 https://doi.org/10.1002/j.1552-4604.1975.tb01442.xAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Loomis, T. A.: Essentials of Toxicology. Philadelphia, Lea and Febiger, 1968. 2 Schimmel, E. M.: Hazards of hospitalization. Ann. Int. Med. 60: 100 (1964). 3 MacDonald, M. G., and MacKay, B. R.: Adverse drug reactions; experience of Mary Fletcher Hospital during 1962. J.A.M.A. 19: 1071 (1964). 4 Wintrobe, M. M.: Reporting of adverse reactions to drugs. Ann. Int. Med. 62: 170 (1965). 5 Council on Drugs: Reporting adverse drug reactions. J.A.M.A. 196: 429 (1966). 6 Seidl, L. G., Thornton, G. F., Smith, J. W., and Cluff, L. E.: Studies on epidemiology of adverse drug reactions. III. Reactions in patients on general medical service. Bull. Johns Hopkins Hosp. 119: 299 (1966). 7 Ogilvie, R. I., and Ruedy, J.: Adverse drug reactions during hospitalization. Canad. Med. Assn. J. 97: 1450 (1967). 8 Sidel, V. W., Koch-Wester, J., Barnett, G. O., and Eaton, A. E.: Drug utilization and adverse drug reactions in general hospital. Hospitals and Health Rev. 41: 80 (1967). 9 Long, J. W.: FDA's adverse drug reaction information system. Drug Information Bull. 1: 114 (1967). 10 Ruskin, A.: Drug experience reporting: new Adverse Reactions Task Force. FDA Papers 1(3): 13 (April 1967). 11 Jick, H., Slone, D., Borda, I. T., and Shapiro, S.: Efficacy and toxicity of heparin in relation to age and sex. New England J. Med. 279: 284 (1968). 12 Koch-Weser, J.: Definition and classification of adverse drug reactions. Drug Information Bull. 2: 72 (1968). 13 Wittes, J., and Sidel, V. W.: A generalization of the simple capture-recapture model with applications to epidemiological research. J. Chron. Dis. 21: 287 (1968). 14 Martin, E. W.: Hazards of Medication. A Manual of Drug Interactions, Incompatibilities, Contraindications, and Adverse Effects. Philadelphia, Lippincott, 1971, p. 1. 15 Thienes, C. H., and Haley, T. J.: Clinical Toxicology. Philadelphia, Lea and Febiger, 1972, p. 2. 16 Meyler, L., and Peck, H. M.: Drug- Induced Diseases. Amsterdam, Excerpta Medica, 1972. 17 Marks, R. M., and Sacher, E. J.: Under-treatment of medical inpatients with narcotic analgesics. Ann. Int. Med. 78: 173 (1973). 18 U.S. Department of Health, Education and Welfare. Secretary's Commission on Medical Malpractice. Medical Malpractices; Report. Washington, D.C., U.S. Govt. Printing Office, 1973. 19 Goldstein, A.: A controlled comparison of the project method with standard laboratory teaching in pharmacology. J. Med. Educ. 31: 365 (1956). 20 Kahn, J. B., Jr.: The pharmacology laboratory; teaching tool or sacrament? J. Med. Educ. 40: 870 (1965). 21 Mandel, H. G., Cohn, V. H., and Straw, J. A.: The value of laboratory teaching in pharmacology. J. Med. Educ. 46: 69 (1971). 22 Raisfeld, I. H.: Clinical pharmacology of drug interactions. Ann. Rev. Med. 24: 385 (1973). 23 LaDu, B. N., Mandel, H. G., and Way, E. L.: Fundamentals of drug metabolism and drug disposition. Baltimore, Williams and Wilkins, 1971. 24 Brodie, B. B., and Gillette, J. R.: Concepts in biochemical pharmacology. Handbook of Experimental Pharmacology, Vol. XXVIII, Parts 1 and 2. New York, Springer, 1971. 25 Hansten, P. D.: Drug Interactions. Philadelphia, Lea and Febiger, 1973. 26 Ebadi, M. S., and Kugel, R. B.: Alteration in metabolism of acetylsalicylic acid in children with Down's syndrome: decreased plasma binding and formation of salicyluric acid. Pediat. Res. 4: 187 (1970). 27 Ebadi, M. S.: The pharmacokinetic basis of meaningful therapeutic in medicine, with special reference to drugs commonly used in neurological diseases. Advan. Neurol., to be published. 28 Livingston, S.: Comprehensive Management of epilepsy in infancy, childhood and adolescence. Springfield, Charles C Thomas, 1972. 29 Woodbury, D. M., Penry, J. K., and Schmidt, R. P.: Antiepileptic drugs. New York, Raven Press, 1972. 30 Price, P. B., Lewis, E. G., Loughmiller, G. C., Nelson, D. E., Murray, S. L., and Taylor, C. W., Attributes of a good practicing physician. J. Med. Educ. 46: 229 (1971). 31 Moore, F. J.: Information Technologies and Health Care. Arch. Int. Med. 125: 503 (1970). 32 Burns, L. E., Hodgman, J. E., and Cass, A. B.: Fatal circulatory collapse in premature infants receiving chloramphenicol. New England J. Med. 261: 1318 (1959). 33 Lambdin, M. A., Jr., Waddell, W. W., and Birdsong, M.: Chloramphenicol toxicity in the premature infant. Pediatrics 25: 935 (1960). 34 Brown, A. K., and Zuelzer, W. W.: Studies on the neonatal development of the glucuronide conjugating system. J. Clin. Invest. 37: 332 (1958). 35 Odell, G. B.: The dissociation of bilirubin from albumin and its clinical implications. J. Pediat. 55: 268 (1959). 36 Glazko, A. J., Wolf, L. M., Dill, W. A., and Bratton, A. C., Jr.: Biochemical studies on chloramphenicol (Chloromycetin): tissue distribution and excretion studies. J. Pharmacol. Exp. Therap. 96: 445 (1949). 37 Dorn, A., and Smith, M.: Blood levels of the palmitate ester of chloramphenicol in infants and children. A.M.A. J. Dis. Child. 98: 665 (1959). 38 Potter, E. L., and Thierstein, S.: Glomerular development in kidney, as an index of fetal immaturity. J. Pediat. 22: 695 (1943). 39 McCance, R. A.: Renal physiology in infancy. Amer. J. Med. 9: 229 (1950). 40 Barnett, H. L.: Kidney function in young infants. Pediatrics 5: 171 (1950). 41 Barnett, H. L., and Vesterdal, I.: Physiologic and clinical significance of immaturity of kidney function in young infants. J. Pediat. 42: 99 (1953). 42 Jondorf, W. R., Maickel, R. P., and Brodie, B. B.: Inability of newborn mice and guinea pigs to metabolize drugs. Biochem. Pharmacol. 1: 352 (1958). 43 Duvoisin, R. C., Yahr, M. D., and Cotc, L. D.: Pyridoxine reversal of l-dopa effect in parkinsonism. Trans. Amer. Neur. Assoc. 94: 81 (1969). 44 Duvosin, R. C.: Pyridoxine as an adjunct in the treatment of parkinsonism. Advan. Neurol. 2: 229 (1973). 45 Davis, V. E., and Awapara, J.: A method for the determination of some amino acid decarboxylase. J. Biol. Chem. 235: 124 (1960). 46 Marrocco, M.: AAAS fellows on the Hill bring scientific SAVVY to a congress of lawyers. Bull. Amer. Assoc. Advan. Sci. 19 (No. 1): 1 (1974). Volume15, Issue4April 1975Pages 230-240 ReferencesRelatedInformation
Publication Year: 1975
Publication Date: 1975-04-01
Language: en
Type: article
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 1
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot